FIB 4 Score (Liver Fibrosis) and Attending Level of Vitamin D in Chronic Hepatitis C Patients
FIB 4 Score (Liver Fibrosis)
DOI:
https://doi.org/10.54393/pjhs.v4i06.811Keywords:
FIB 4 Score, Liver Fibrosis, Level, Vitamin D, Chronic, Hepatitis C, PatientsAbstract
Millions of people around the world are affected by chronic hepatitis C (HCV), which is a global health issue. It is a major contributor to chronic liver conditions such as cirrhosis, hepatocellular carcinoma, and liver fibrosis. For optimal therapy and intervention, prompt identification of liver fibrosis is essential. The rate of hepatic fibrosis progression in HCV-infected patients varies substantially. Objective: To evaluate the vitamin D level and liver fibrosis degree by non-invasive Fib 4 score among chronic hepatitis patients. Methods: This Cross-sectional study was conducted at a tertiary care hospital in Karachi, Pakistan, from August 2020 to September 2022. 65 participants were recruited through a non-probability sampling technique. Results: Study findings show that 21.9% of the patients have low risk for advanced fibrosis, whereas 9.2% have an Intermediate risk for advanced fibrosis, and 69.2% have a high risk for advanced fibrosis. Moreover, findings also revealed that among 65 patients, 66.2% have a deficient amount of Vitamin D, whereas 16.9% have an insufficient amount of Vitamin D level and 16.9% have a sufficient amount of vitamin D. Furthermore, the findings also showed significant association based on p-value (0.001) between Age and Fib4 score of the participant. Conclusions: In conclusion, the study revealed that a significant proportion of chronic hepatitis C patients were at high risk for advanced fibrosis, while vitamin D deficiency/ insufficiency were prevalent among the majority of the patients.
References
Craxì A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Molecular Aspects of Medicine. 2008 Feb; 29(1-2): 85-95. doi: 10.1016/j.mam.2007.09.017. DOI: https://doi.org/10.1016/j.mam.2007.09.017
Cheemerla S and Balakrishnan M. Global epidemiology of chronic liver disease. Clinical Liver Disease. 2021 May; 17(5): 365. doi: 10.1002/cld.1061. DOI: https://doi.org/10.1002/cld.1061
Fallatah H. Noninvasive biomarkers of liver fibrosis: An overview. Advances in Hepatology. 2014 Apr; 2014: 1-15. doi: 10.1155/2014/357287. DOI: https://doi.org/10.1155/2014/357287
Cimini FA, Barchetta I, Carotti S, Bertoccini L, Baroni MG, Vespasiani-Gentilucci U, et al. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2017 May; 23(19): 3407. doi: 10.3748/wjg.v23.i19.3407. DOI: https://doi.org/10.3748/wjg.v23.i19.3407
Tamaki N, Kurosaki M, Tanaka K, Suzuki Y, Hoshioka Y, Kato T, et al. Noninvasive estimation of fibrosis progression overtime using the FIB‐4 index in chronic hepatitis C. Journal of Viral Hepatitis. 2013 May; 20(1): 72-6. doi: 10.1111/j.1365-2893.2012.01635.x. DOI: https://doi.org/10.1111/j.1365-2893.2012.01635.x
von Websky K, Hasan AA, Reichetzeder C, Tsuprykov O, Hocher B. Impact of vitamin D on pregnancy-related disorders and on offspring outcome. The Journal of steroid Biochemistry and Molecular Biology. 2018 Jun; 180: 51-64. doi: 10.1016/j.jsbmb.2017.11.008. DOI: https://doi.org/10.1016/j.jsbmb.2017.11.008
Udomsinprasert W and Jittikoon J. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies. Biomedicine & Pharmacotherapy. 2019 Jan; 109: 1351-60. doi: 10.1016/j.biopha.2018.10.140. DOI: https://doi.org/10.1016/j.biopha.2018.10.140
Hoan NX, Van Tong H, Meyer CG, Velavan TP. Vitamin D deficiency and hepatitis viruses-associated liver diseases: a literature review. World Journal of Gastroenterology. 2018 Jan; 24(4): 445. doi: 10.3748/wjg.v24.i4.445. DOI: https://doi.org/10.3748/wjg.v24.i4.445
Beilfuss A, Sowa JP, Sydor S, Beste M, Bechmann LP, Schlattjan M, et al. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently. Gut. 2015 May; 64(5): 791-9. doi: 10.1136/gutjnl-2014-307024. DOI: https://doi.org/10.1136/gutjnl-2014-307024
de Lucca Schiavon L, Narciso-Schiavon JL, de Carvalho-Filho RJ. Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World journal of gastroenterology: WJG. 2014 Mar; 20(11): 2854. doi: 10.3748/wjg.v20.i11.2854. DOI: https://doi.org/10.3748/wjg.v20.i11.2854
Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011 Jan; 53(1): 325-35. doi: 10.1002/hep.24013. DOI: https://doi.org/10.1002/hep.24013
Iruzubieta P, Terán Á, Crespo J, Fábrega E. Vitamin D deficiency in chronic liver disease. World Journal of Hepatology. 2014 Dec; 6(12): 901. doi: 10.4254/wjh.v6.i12.901. DOI: https://doi.org/10.4254/wjh.v6.i12.901
Fisher L and Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clinical gastroenterology and Hepatology. 2007 Apr; 5(4): 513-20. doi: 10.1016/j.cgh.2006.10.015. DOI: https://doi.org/10.1016/j.cgh.2006.10.015
Luger M, Kruschitz R, Kienbacher C, Traussnigg S, Langer FB, Schindler K, et al. Prevalence of liver fibrosis and its association with non-invasive fibrosis and metabolic markers in morbidly obese patients with vitamin D deficiency. Obesity Surgery. 2016 Oct; 26: 2425-32. doi: 10.1007/s11695-016-2123-2. DOI: https://doi.org/10.1007/s11695-016-2123-2
Arteh J, Narra S, Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Digestive Diseases and Sciences. 2010 Sep; 55: 2624-8. doi: 10.1007/s10620-009-1069-9. DOI: https://doi.org/10.1007/s10620-009-1069-9
Pérez-López FR. Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas. 2007 Oct; 58(2): 117-37. doi: 10.1016/j.maturitas.2007.05.002. DOI: https://doi.org/10.1016/j.maturitas.2007.05.002
Poynard T, Lebray P, Ingiliz P, Varaut A, Varsat B, Ngo Y, et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterology. 2010 Dec; 10(1): 1-3. doi: 10.1186/1471-230X-10-40. DOI: https://doi.org/10.1186/1471-230X-10-40
Caballería L, Pera G, Arteaga I, Rodríguez L, Alumà A, Morillas RM, et al. High prevalence of liver fibrosis among European adults with unknown liver disease: a population-based study. Clinical Gastroenterology and Hepatology. 2018 Jul; 16(7): 1138-45. doi: 10.1016/j.cgh.2017.12.048. DOI: https://doi.org/10.1016/j.cgh.2017.12.048
Nah EH, Cho S, Kim S, Chu J, Kwon E, Cho HI. Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional study. BMJ Open. 2021 Mar; 11(3): e046529. doi: 10.1136/bmjopen-2020-046529. DOI: https://doi.org/10.1136/bmjopen-2020-046529
Ebadi M, Ip S, Bhanji RA, Montano-Loza AJ. Effect of coffee consumption on non-alcoholic fatty liver disease incidence, prevalence and risk of significant liver fibrosis: Systematic review with meta-analysis of observational studies. Nutrients. 2021 Aug; 13(9): 3042. doi: 10.3390/nu13093042. DOI: https://doi.org/10.3390/nu13093042
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
